what do glp-1 receptor agonists do GLP1 Receptor Agonists—Effects beyond Obesity
Description
This is a huge market
Results show broad benefits with a reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions
19, 2024 (HealthDay News) -- The U.S
The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031
Depression is a highly prevalent mood disorder and one of the major health concerns in modern society
